Medtronic Statistics
Total Valuation
Medtronic has a market cap or net worth of $101.91 billion. The enterprise value is $118.93 billion.
| Market Cap | 101.91B |
| Enterprise Value | 118.93B |
Important Dates
The next estimated earnings date is Tuesday, August 20, 2024, before market open.
| Earnings Date | Aug 20, 2024 |
| Ex-Dividend Date | Jun 28, 2024 |
Share Statistics
Medtronic has 1.28 billion shares outstanding. The number of shares has decreased by -0.20% in one year.
| Shares Outstanding | 1.28B |
| Shares Change (YoY) | -0.20% |
| Shares Change (QoQ) | -0.61% |
| Owned by Insiders (%) | 0.11% |
| Owned by Institutions (%) | 88.57% |
| Float | 1.28B |
Valuation Ratios
The trailing PE ratio is 28.80 and the forward PE ratio is 14.87. Medtronic's PEG ratio is 1.52.
| PE Ratio | 28.80 |
| Forward PE | 14.87 |
| PS Ratio | 3.15 |
| Forward PS | 3.07 |
| PB Ratio | 2.03 |
| P/FCF Ratio | 19.60 |
| PEG Ratio | 1.52 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.55, with an EV/FCF ratio of 22.87.
| EV / Earnings | 32.35 |
| EV / Sales | 3.67 |
| EV / EBITDA | 14.55 |
| EV / EBIT | 21.51 |
| EV / FCF | 22.87 |
Financial Position
The company has a current ratio of 2.03, with a Debt / Equity ratio of 0.50.
| Current Ratio | 2.03 |
| Quick Ratio | 1.31 |
| Debt / Equity | 0.50 |
| Debt / EBITDA | 3.06 |
| Debt / FCF | 4.81 |
| Interest Coverage | 7.69 |
Financial Efficiency
Return on equity (ROE) is 7.20% and return on invested capital (ROIC) is 5.23%.
| Return on Equity (ROE) | 7.20% |
| Return on Assets (ROA) | 4.10% |
| Return on Capital (ROIC) | 5.23% |
| Revenue Per Employee | $340,674 |
| Profits Per Employee | $38,695 |
| Employee Count | 95,000 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 2.13 |
Taxes
In the past 12 months, Medtronic has paid $1.13 billion in taxes.
| Income Tax | 1.13B |
| Effective Tax Rate | 23.56% |
Stock Price Statistics
The stock price has decreased by -7.71% in the last 52 weeks. The beta is 0.83, so Medtronic's price volatility has been lower than the market average.
| Beta (5Y) | 0.83 |
| 52-Week Price Change | -7.71% |
| 50-Day Moving Average | 81.08 |
| 200-Day Moving Average | 80.94 |
| Relative Strength Index (RSI) | 50.22 |
| Average Volume (20 Days) | 6,830,373 |
Short Selling Information
The latest short interest is 15.22 million, so 1.19% of the outstanding shares have been sold short.
| Short Interest | 15.22M |
| Short Previous Month | 13.32M |
| Short % of Shares Out | 1.19% |
| Short % of Float | 1.19% |
| Short Ratio (days to cover) | 2.18 |
Income Statement
In the last 12 months, Medtronic had revenue of $32.36 billion and earned $3.68 billion in profits. Earnings per share was $2.76.
| Revenue | 32.36B |
| Gross Profit | 21.15B |
| Operating Income | 5.15B |
| Pretax Income | 4.81B |
| Net Income | 3.68B |
| EBITDA | 8.18B |
| EBIT | 5.53B |
| Earnings Per Share (EPS) | $2.76 |
Balance Sheet
The company has $8.01 billion in cash and $25.02 billion in debt, giving a net cash position of -$17.02 billion or -$13.27 per share.
| Cash & Cash Equivalents | 8.01B |
| Total Debt | 25.02B |
| Net Cash | -17.02B |
| Net Cash Per Share | -$13.27 |
| Equity (Book Value) | 50.21B |
| Book Value Per Share | 39.16 |
| Working Capital | 11.15B |
Cash Flow
In the last 12 months, operating cash flow was $6.79 billion and capital expenditures -$1.59 billion, giving a free cash flow of $5.20 billion.
| Operating Cash Flow | 6.79B |
| Capital Expenditures | -1.59B |
| Free Cash Flow | 5.20B |
| FCF Per Share | $3.92 |
Margins
Gross margin is 65.34%, with operating and profit margins of 15.90% and 11.36%.
| Gross Margin | 65.34% |
| Operating Margin | 15.90% |
| Pretax Margin | 14.86% |
| Profit Margin | 11.36% |
| EBITDA Margin | 25.26% |
| EBIT Margin | 17.08% |
| FCF Margin | 16.07% |
Dividends & Yields
This stock pays an annual dividend of $2.80, which amounts to a dividend yield of 3.52%.
| Dividend Per Share | $2.80 |
| Dividend Yield | 3.52% |
| Dividend Growth (YoY) | 1.47% |
| Years of Dividend Growth | 48 |
| Payout Ratio | 101.45% |
| Buyback Yield | 0.20% |
| Shareholder Yield | 3.72% |
| Earnings Yield | 3.61% |
| FCF Yield | 5.10% |
Analyst Forecast
The average price target for Medtronic is $90.82, which is 14.27% higher than the current price. The consensus rating is "Hold".
| Price Target | $90.82 |
| Price Target Difference | 14.27% |
| Analyst Consensus | Hold |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 4.85% |
| EPS Growth Forecast (5Y) | 22.00% |
Stock Splits
The last stock split was on September 27, 1999. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 27, 1999 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Medtronic has an Altman Z-Score of 2.73 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.73 |
| Piotroski F-Score | 7 |